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Prolonged venoarterial extracorporeal membrane oxygenation after
transplantation restores functional integrity of severely injured lung
allografts and prevents the development of pulmonary graft failure in
a pig model
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Objective: Prolonged venoarterial extracorporeal membrane oxygenation support during transplantation
provides reduction of pulmonary artery flow and allows for protective ventilation. This approach might have
the potential to restore function of lungs that would be unsuitable for transplantation.
Methods: Left lung transplantation was performed on 16 pigs. Lungs from brain-dead animals were stored for 22
hours at 4C. Recipients in group A (n¼ 8) underwent transplantation without cardiopulmonary support followed
by ventilation with 10 mL/kg body weight tidal volume. Animals in group B (n ¼ 8) underwent transplantation
during venoarterial extracorporeal membrane oxygenation, which was continued for 22 hours, and received low-
tidal-volume (5 mL/kg body weight) ventilation. One hour after transplantation, the right lung was excluded.
Graft function was compared immediately after exclusion of the contralateral lung (time point 1), 1 hour later
(time point 2), and 1 hour after discontinuation of extracorporeal membrane oxygenation (time point 3).
Results: Four animals in group A did not reach time point 2; all died of pulmonary edema. All animals in group B
survived, and at time point 3, the mean PaO2 value was 323  129 mm Hg. At time point 2, oxygenation and lung
compliance were higher in group B than in group A, whereas pulmonary artery pressure was lower. The same was
true when comparing results of group B at time point 3 with results of group A at time point 2.
Conclusions: Transplantation during extracorporeal membrane oxygenation with continued use for 24 hours
restores function of damaged donor lungs. This could expand the donor pool through wider use of marginal
donors.
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XAccording to the report of the International Society for Heart
and Lung Transplantation, primary pulmonary graft failure
(PGF) accounts for almost one third of early deaths.1 PGF
is a result of repetitive traumatic episodes involving the allo-
graft. Main contributors are brain death, preservation and
storage conditions, and the effects of reperfusion.2
PGF usually presents with the clinical picture of severe
reperfusion edema. Once edema is established, the standard
course of treatment is aggressive ventilation with high
pressure patterns together with intravenous inotropic sup-
port. However, this course of treatment itself causes further
damage to the lung because of overinflation and a further
increase in pulmonary artery pressure (PAP).
From the Departments of Cardiothoracic Surgery,a Anaesthesiology,b and Patho-
logy,c and the Core Unit for Medical Statistics and Informatics,d Medical Uni-
versity of Vienna, Vienna, Austria; and the Department of Thoracic Surgery,e
Catholic University Leuven, Leuven, Belgium.
Supported by an educational grant from Medtronic.
Received for publication Aug 27, 2008; revisions received Oct 22, 2008; accepted for
publication Nov 15, 2008.
Address for reprints: Walter Klepetko, MD, Department of Thoracic Surgery, Medical
University of Vienna, Allgemeines Krankenhaus, Wa¨hringer Gu¨rtel 18-20, A-1090
Vienna, Austria (E-mail: walter.klepetko@meduniwien.ac.at).
J Thorac Cardiovasc Surg 2009;137:1493-8
0022-5223/$36.00
Copyright  2009 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2008.11.064The Journal of Thoracic and CaThe importance of controlled low-pressure perfusion, as
well as protective low-tidal-volume ventilation, for recovery
of injured lungs has been demonstrated in several clinical
and experimental reports.3-7 In lung transplantation both
controlled low-pressure perfusion and low-tidal-volume
ventilation can be provided by venoarterial extracorporeal
membrane oxygenation (ECMO). Usually, ECMO is ap-
plied for the treatment of already established graft failure.8,9
However, it can also be used intraoperatively as an alterna-
tive to cardiopulmonary bypass (CPB) and then be pro-
longed into the postoperative period to provide optimal
reperfusion conditions to the transplanted allograft.10 In
our clinical experience with this approach, we have seen
excellent initial graft function, even with very marginal
donor organs.
The aim of the study was to investigate the effect of intra-
operative and prolonged postoperative ECMO support on
the early allograft function of critically injured donor lungs
in a standardized experimental transplantation setting.
MATERIALS AND METHODS
The study was performed in accordance with the Austrian Animal
Research Statute (1988) and was approved by the local ethics committee
of the Medical Faculty, University of Vienna, Vienna, Austria. Furthermore,
the study was conducted in compliance with the principles of laboratory
animal care formulated by the National Society for Medical Research and
the ‘‘Guide for the care and use of laboratory animals,’’ prepared by therdiovascular Surgery c Volume 137, Number 6 1493
Cardiothoracic Transplantation Lang et al
T
XAbbreviations and Acronyms
ARDS ¼ acute respiratory distress syndrome
BW ¼ body weight
CO ¼ cardiac output
CPB ¼ cardiopulmonary bypass
ECMO ¼ extracorporeal membrane oxygenation
FIO2 ¼ fraction of inspired oxygen
PAP ¼ pulmonary artery pressure
PGF ¼ pulmonary graft failure
National Institutes of Health (National Institutes of Health publication no.
96-03, revised 1996).
Experimental Groups
Thirty-two healthy pigs (German large white pigs) were used. Sixteen
served as brain-dead donors, and 16 served as recipients. Four hours after
induction of brain death, the donor lungs were harvested and stored for
a cold ischemic period of 22 hours. The transplantation procedure was
a left single lung transplantation followed by crossclamping of the right
lung 1 hour after reperfusion.
The 16 recipient pigs were divided into 2 groups. Group A consisted of 8
pigs undergoing transplantation without ECMO support with standard post-
operative ventilation at 10 mL/kg body weight (BW). Group B consisted of
8 pigs undergoing transplantation with intraoperative and postoperative (22
hours) ECMO support receiving protective low-tidal-volume postoperative
ventilation at 5 mL/kg BW.
Functional assessment was performed 10 minutes after exclusion of the
contralateral right lung (time point 1), 1 hour later (time point 2), and 22
hours later in group B (ie, 1 hour after weaning from ECMO; time point
3). Graft function was compared between the groups by measuring oxygen-
ation, PAP, dynamic lung compliance, and extravascular lung water content
(wet/dry weight ratio).
Donor Procedure
Anesthesia. An arterial line for invasive pressure monitoring (Smiths
Medical, Kirchseeon, Germany) was placed in the right internal carotid
artery. A venous line for drugs and fluid replacement was placed in the
internal jugular vein. For introduction of a Swan–Ganz catheter (size
7.5F, Vigilance; Edward Lifesciences, Irvine, Calif), the external jugular
vein was used. Urine output was monitored through a balloon catheter intro-
duced through a suprasymphyseal lower median laparotomy. Premedication
consisted of 20 mg/kg ketamine (Ketavet; Pharmacia–Upjohn, Uppsala,
Sweden) plus 1.76 mg/kg acepromazine (Vanastress; Vana, Vienna, Aus-
tria) administered intramuscularly. Anesthesia was introduced with 15
mg/kg thiopental, 15 mg of piritramid (Dipidolor; Janssen-Cilag Pharma,
Wien, Austria), and 20 mg of rocuronium bromide (Esmeron; Organon,
Oss, The Netherlands) administered intravenously and maintained with
0.1 mg $ kg1 $ h1 piritramid, 10 mg $ kg1 $ h1 propofol (Propofol Fre-
senius 2%; Fresenius Kabi, Linz, Austria), and 0.1 mg $ kg1 $ h1 rocuro-
nium bromide administered intravenously for muscle relaxation. All
animals were fully heparinized with 300 IU/kg BW Na-Heparin (Heparin
Immuno; EBEWE Pharma, Unterach Austria) administered intravenously
before cross clamping of the aorta. Animals were intubated with endotra-
cheal tube Ch 8 (Ru¨sch, Kernen, Germany) and a ventilator (Dra¨ger Primus;
Dra¨ger, Luebeck, Germany), and settings were as follows: tidal volume, 10
mL/kg BW; frequency, 20/min; fraction of inspired oxygen (FIO2), 0.5 to
1.0; inspiratory/expiratory time ratio, 1:2; positive end-expiratory pressure,
5 cm H2O; and end-tidal CO2 target value, 40 mm Hg.1494 The Journal of Thoracic and Cardiovascular SuBrain death procedure. After induction and maintenance of
anesthesia, animals were placed in a ventral decubitus position. A balloon
catheter was placed over the dura mater and pushed into the extradural
space. Gradual balloon inflation with 25 mL of fluid (10þ5þ5 mL/10 min-
utes and 5 mL after a further 30 minutes) caused brain death. Lungs were
harvested 4 hours later.
Lung harvesting. In contrast to the clinical routine, donor animals did
not receive steroid medication to avoid any possible effect on pathways of
the brain death–induced lung injury. The brain-dead pig was placed in the
dorsal position, and a longitudinal sternotomy was performed. An inflow
catheter was placed in the pulmonary artery through a purse-string suture
on the right ventricular outflow tract. Both caval veins, together with the
ascending aorta, were crossclamped, and the left auricular appendix was
incised to provide drainage. The lungs were then perfused with an antegrade
flush of 50 mL/kg cold low potassium dextran solution (Perfadex; Vitrolife,
Gothenburg, Sweden) supplemented with 0.3 mL/L Tris buffer. Then an ice
slush was placed in both pleural cavities and the mediastinum. During this
period, the lungs were ventilated with 50% oxygen. En bloc harvesting of
the heart and lungs together with the esophagus was performed, and before
closure of the trachea with a stapler, the donor lungs were moderately in-
flated. Organs were then wrapped in gauze, placed in an insulated ice bag
filled with low potassium dextran solution, and stored at 4C for 22 hours.
Recipient Procedure
Anesthesia. Anesthesia for the recipient animals was identical as for the
donor pigs. One single dose of 5000 IU Na-Heparin and 500 mg of imipe-
nem (Tienam; Merck Sharp & Dohme, Haarlem, The Netherlands) was
administered intravenously. Immunosuppression consisted of a single intra-
venous dose of 500 mg of methylprednisolone (Solu-Medrol, Pharmacia–
Upjohn) administered immediately before reperfusion.
Implantation. The donor lung was then reimplanted with 4-0 polydiox-
anone running sutures for the bronchial anastomosis and 5-0 Prolene sutures
for the pulmonary artery and left atrium. The implanted lung underwent ret-
rograde and antegrade deairing and flushing according to standard proce-
dures. Thereafter, the arterial clamp was partially released for 10 minutes
to provide controlled reperfusion. One hour later, the bronchus and artery
of the contralateral right lung were crossclamped. Ventilation to the trans-
planted lung was begun during reperfusion by using the standard method
in group A and by using low tidal volumes in group B. At the end of the ex-
periments, animals were killed by clamping of the left pulmonary artery.
ECMO management. For the animals in group B, the Medtronic
Biomedicus portable bypass system with a hollow-fiber oxygenator
(Medtronic CPMPCB Affinity BPX-80; Medtronic, Minneapolis, Minn)
and an integrated heat exchanger was used for ECMO support. After thora-
cotomy, direct central cannulation of the ascending aorta (Medtronic DLP
22F Curved Tip) and the inferior caval vein (Medtronic DLP 32F Single
Stage) was performed. Both the cannulae and the circuit were heparin coated
(Medtronic Carmeda BioActive Surface). Priming solution was 200 mL of
Ringer’s Lactate solution. The flow was set at 50% of initial cardiac output
(CO). This support was maintained throughout the whole transplantation
procedure and continued for a further 22 hours. Thereafter, the pig was grad-
ually weaned from ECMO. One hour later, the final functional assessment
(time point 3) was performed.
Assessments
All arterial blood gas samples were taken from the right internal ca-
rotid artery after a test ventilation period of at least 10 minutes at an
FIO2 of 1.0 (ABL800 Flex Radiometer, Copenhagen, Denmark). Heart
rate, arterial blood pressure, oxygen saturation, central venous pressure,
and PAP were continuously monitored (PPG Hellige, Freiburg, Ger-
many). Dynamic compliance was measured with a volume-controlled
ventilator (Dra¨ger Primus; Dra¨gerwerk, Luebeck, Germany). Lung bi-
opsy samples were taken from the anterior margin of the lower lobe.rgery c June 2009
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80C. Lung water was calculated by using the following formula:
% Tissue water ¼ ð½Wet weightDry weight=Wet weightÞ3100:
We checked the distributions of all variables for symmetry by comparing
means with medians and ranges and found no unusually skewed distribu-
tions. Therefore animal characteristics were described as means and stan-
dard deviations and compared between groups with independent-samples
t tests. Outcome measures were compared between groups by using re-
peated-measures analysis of variance specifying a first-order autoregressive
covariance structure. An interaction of group with time was assessed, and if
the interaction was significant, Bonferroni–Holm–corrected P values com-
paring groups at different time points were computed. Otherwise, the group
difference was assumed to be equal across all time points, and a common P
value was computed from the repeated-measures analysis of variance model.
This analysis was repeated, replacing original values with their ranks, to see
whether results depended on the assumption of normal distribution. There
was no difference in the pattern of significances between both analyses sug-
gesting robust results. There were also no relevant changes by specifying
different types of covariance structures. Survival was compared with the ex-
act log-rank test.11 All tests were 2-sided. The SAS System (version 9.2,
2008; SAS Institute, Inc, Cary, NC) was used for statistical computations.
RESULTS
There was no important difference between the study
groups regarding baseline variables (Table 1).
Survival
Survival was better in group B than in group A (100% vs
50% at time point 2, P ¼ .026).
In group A all animals died of lung edema and hypoxia.
One pig died 28 minutes after reperfusion and did not reach
time point 1. Three other pigs died before time point 2. Of
the remaining 4 pigs, 2 died immediately after time point
2, and the others died 3 hours later.
In group B all animals survived and were successfully
weaned from ECMO after 22 hours except 1. This animal
showed critical hemodynamic instability after 3 weaning
TABLE 1. Baseline variables
Group A Group B
P value
(t test)
Recipient weight (kg) 54  4 57  8 >.2
Donor weight (kg) 59  5 60  9 >.2
P/F ratio before BD (mm Hg) 500  82 532  44 >.2
Compliance before BD (mL/cm H2O) 31  5 33  5 >.2
Wet/dry ratio% before BD 82.1  2.6 80.7  2.9 >.2
Mean PAP before BD (mm Hg) 19.9  1.1 20  1.9 >.2
Time BD–CC (min) 268  37 263  72 >.2
P/F ratio 4 h after BD (mm Hg) 501  48 505  33 >.2
Compliance 4 h after BD (mL/cm H2O) 32  8 32  5 >.2
Wet/dry ratio% 4 h after BD 82.4  1.3 80.7  2.9 >.2
Mean PAP 4 h after BD (mm Hg) 18.1  2.0 18  2.1 >.2
CIT (min) 1281  76 1312  80 >.2
Mean PAP, baseline recipient (mm Hg) 20.8  2.3 20.3  1.6 >.2
Values are presented as the mean  standard error of the mean, where shown. P/F,
PaO2/FIO2; BD, brain death; CC, time of crossclamping of the donor aorta; PAP, pul-
monary artery pressure; CIT, cold ischemic time.The Journal of Thoracic and Cattempts but without signs of lung edema. The other 7 pigs
remained in stable condition after time point 3, and no trend
toward deterioration was observed over the following 3
hours. Thereafter, the experiments were terminated.
Functional Performance
Oxygenation. There was no difference between group A
and group B regarding PaO2/FIO2 ratio either after reperfu-
sion (291  88 vs 338  73 mm Hg, respectively; P> .2)
or 10 minutes after becoming dependent from the allograft
(time point 1; 137  148 vs 150  87 mm Hg, respectively;
P> .2). At time point 2, the mean PaO2/FIO2 ratio of the
surviving 4 animals in group A was worse than that in group
B (96  41 vs 178  114 mm Hg, P> .2). One hour after
weaning from ECMO (time point 3), pigs in group B showed
excellent allograft function (323  129 mm Hg). When the
corresponding values for 1-hour dependency from the new
lung in the 2 groups (group A, time point 2; group B, time
point 3) were compared, better results were seen in group
B (96  41 vs 323  129 mm Hg, P ¼ .002; Figure 1).
Pulmonary artery pressure. Mean PAP was higher in
group A than in group B both after pneumonectomy and
immediately after reperfusion (28.5  4.5 vs 18.6  3.9
mm Hg, P ¼ .002, and 28.9  7.2 vs 18.8  2.1 mm Hg,
P ¼ .002, respectively). At time point 1, there was also
some difference in mean PAP values between group A and
group B (38.4  7.7 vs 32.9  7.1 mm Hg, respectively;
P ¼ .048). At time point 2, the mean PAP of the surviving
4 animals in group A was higher than that in group B (45.3
 4.1 vs 33.6 4 mm Hg, P¼ .006). One hour after weaning
from ECMO (time point 3), pigs in group B showed almost
normal mean PAPs (24.1  5.4 mm Hg). Again, when com-
paring this value with the mean PAP at time point 2 in group
A (45.3  4.1 mm Hg), the difference is highly in favor of
group B (P< .001).
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FIGURE 1. Mean arterial PaO2 at a fraction of inspired oxygen (FIO2) of
1.0 in function of time. Values are shown as mean levels. BD, Brain death;
TP1, time point 1 (immediately after exclusion of the right lung); TP2, time
point 2 (1 hour after exclusion of the right lung); TP3, time point 3 (1 hour
after discontinuation of extracorporeal membrane oxygenation).ardiovascular Surgery c Volume 137, Number 6 1495
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mL/cm H2O in group A versus 13  3 mL/cm H2O in group
B (P>.2), and at time point 2, it was 11  1 mL/cm H2O vs
14 3 mL/cm H2O, respectively (P>.2). Again, comparing
compliance of group A at time point 2 with compliance of
group B at time point 3, the allografts in the ECMO group
performed better (11  1 vs 16  5 cm H2O, P> .2).
Wet/dry ratio. Differences between study groups regard-
ing lung water content could be due to chance. The wet/
dry ratio was 82.7%  4.2% in group A versus 76.0%
 7.4% in group B at time point 1 (P> .2), 78.5% 
3.5% in group A versus 76.8%  5.3% in group B at
time point 2 (P> .2), and 76.9%  9.1% in group B at
time point 3.
DISCUSSION
The findings of this study demonstrate that severely
injured lung allografts can successfully be transplanted
when optimal conditions during the initial reperfusion
period are provided. These organs, derived from brain-
dead donors and undergoing a 22-hour cold ischemic storage
period, uniformly result in lung edema and PGF when trans-
planted in a conventional way. The combination of a reduc-
tion of the circulatory blood volume passing the pulmonary
vascular bed during an extended reperfusion period of 22
hours together with the application of protective low-volume
ventilation, however, allows the allograft to recover and pre-
vents the onset of a cascade of events that ultimately would
result in development of PGF.
The starting point of lung injury during transplantation
begins with the brain death of the donor.12,13 The nonphy-
siologic composition and temperature of the cold preserva-
tion fluid represent further stresses to the endothelium.
This is followed by formation of reactive oxygen species
during cold ischemic storage. Endothelial cells under such
conditions become sensitive to mechanical forces and react
with electrophysiologic and biochemical consequences.2
Given the complexity of lung ischemia–reperfusion injury
mechanisms, there are a number of possible approaches to
counteract this, such as limiting the deleterious effects of
brain death, optimizing perfusion and storage conditions,
and, most importantly, interrupting the developing cascade
of injury during the reperfusion itself.
The first data on the importance of controlled reperfusion
were derived from experimental studies. Okamoto, Allen,
and colleagues14,15 demonstrated that 20 minutes of con-
trolled reperfusion are superior to 10 minutes only after
regional ischemia in hearts. Halldorsson and associates3
and Bhabra and coworkers16 proved that reduction of PAP
during the first 10 minutes of reperfusion of transplanted
lungs leads to a clear reduction in the severity of pulmonary
reperfusion injury. However, there are no experimental data
available on whether a substantial prolongation of such
a controlled reperfusion period could be of further benefit.1496 The Journal of Thoracic and Cardiovascular SuAdditional information about the importance of con-
trolled reperfusion comes from clinical experience with
bilateral sequential lung transplantation performed without
CPB. During this procedure, the first transplanted lung is
subjected to complete CO during the implantation of the sec-
ond lung. As a consequence, tissue edema formation and
radiographic infiltrates in the first transplanted lung are com-
mon and known as the first lung syndrome. For these
reasons, some centers prefer to perform bilateral transplanta-
tion routinely with CPB, which offers the possibility for im-
proved reperfusion conditions, especially for the first lung.17
Similar results derive from the experience with ex vivo lung
assessment. Steen and colleagues18 investigated lung allo-
grafts of non–heart beating donors after preservation with
topical cooling. They reported the importance of keeping
the PAP at less than 20 mm Hg during functional assessment
of the grafts by means of ex vivo perfusion. The same prin-
ciple was applied by Egan and associates19 for ex vivo as-
sessment of human lungs.19 All these data suggest that the
reduction of pulmonary artery flow during early reperfusion
is crucial for the prevention of severe reperfusion injury.
However, the optimal length of time to provide such reper-
fusion conditions remains undefined thus far.
Prolongation of controlled reperfusion into the postoper-
ative period is possible with venoarterial ECMO. Ko and
coworkers20 reported their experience in 5 patients with
PPH, in whom they used ECMO during lung transplantation
and for several hours thereafter. All patients had an unevent-
ful transplantation and had excellent organ function after the
procedure. Our own early experience with lung transplanta-
tion during intraoperative and postoperatively prolonged
ECMO was gained from patients with severe pulmonary
hypertension. Seventeen patients underwent transplantation
in this way, and initial organ function was excellent in all of
them.10 After this experience, we expanded the use of
ECMO for lung transplantation in our department until it
finally replaced the use of CPB as the standard method com-
pletely.9 In addition to the resulting reduction in pulmonary
flow, it was possible to apply extremely protective ventila-
tion conditions.
The importance of such a low-pressure, low-tidal-volume
ventilation for prevention of lung damage, as well as for
recovery of already injured lungs, has been demonstrated re-
peatedly. Traditional approaches to mechanical ventilation
use tidal volumes of 10 to 15 mL/kg BW. In animal exper-
iments it has been demonstrated that ventilation with such
large tidal volumes causes disruption of the pulmonary epi-
thelium and endothelium and subsequently leads to lung
inflammation and release of inflammatory mediators.21,22
Similar experience comes from a single lung transplantation
study in rat lungs.23 These experimental findings are in line
with clinical observations. In a controlled, multicenter ran-
domized trial of the Acute Respiratory Distress Syndrome
(ARDS) network on 861 patients with acute lung injury orrgery c June 2009
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aggressive respiratory pattern with lower tidal volumes
than traditionally used resulted in improved clinical out-
come.5 These data support the view that aggressive ventila-
tion patterns, although sometimes necessary to provide
adequate oxygenation, contribute to the exacerbation and
perpetuation of lung injury itself. This is precisely the situa-
tion that is of importance for a lung allograft in the period of
reperfusion.
ECMO has been used in a wide spectrum of indications,
including clinical lung transplantation and treatment of
severe lung injury. Recently, its efficiency for treatment of
severe forms of ARDS has been described.24 In this situation
ECMO maintains gas exchange and provides optimal condi-
tions for lung recovery by allowing the use of nondamaging
ventilator settings. A similar approach, based on the concept
‘‘to put the lung to rest’’ to achieve better conditions for
recovery, was described by Iglesias and associate.25 They
used near-static ventilation for patients with severe ARDS
while providing gas exchange over a pumpless extracorpo-
real membrane system (Novalung, Talheim, Germany).
Similar experience has been gained with the use of ECMO
for the treatment of already established posttransplantation
graft failure.26-30 From our own early experience, we were
impressed by the observation that the transplanted lungs
that were in even very severe forms of reperfusion edema
were able to recover within a short period of time once
venoarterial ECMO was installed. From all these reports, it
becomes evident that venoarterial ECMO treatment not
only maintains vital functions during periods of severe
lung injury but even more directly contributes to improved
recovery of the lung by means of 2 factors: reduction of
pulmonary artery flow and avoidance of harmful ventilator
settings.
However, it is certainly difficult to evaluate this clinical
experience on an objective basis given the heterogeneity
of clinical situations. For this reason, we decided to test
the validity of the hypothesis in a standardized experimental
model of severely injured lung allografts. In this model the
combined injury caused by brain death with a prolonged
ischemic time of 22 hours uniformly resulted in the develop-
ment of severe PGF in group A, in which lungs were trans-
planted in a conventional way. The addition of brain death in
our donors obviously contributed significantly to the result-
ing severe organ damage because Steen and colleagues,18 in
a similar setting but without brain death, reported a far better
functional performance of donor lungs. Assessments in this
experiment were performed in accordance to the time points
of clinical importance, which are 10 minutes after cross-
clamping of the contralateral lung (time point 1) and 1
hour thereafter (time point 2). Because animals in group B
at that time were undergoing partial ECMO support, they
were also investigated at time point 3 (1 hour after weaning
from ECMO; ie, after complete dependency on the trans-The Journal of Thoracic and Caplanted lung). Results from time point 3 in group B were
also compared with results from time point 2 in group A
to compare the situation of 1 hour of complete dependency
on the transplanted lung in both groups and because none
of the animals of group A survived long enough to reach
time point 3. The results obtained in this setting were strik-
ing. All animals of group A had severe reperfusion edema
and died before or soon after time point 2. In contrast, all
except 1 of the animals in group B were successfully weaned
from ECMO and showed excellent graft function, which was
maintained for several hours. The 1 animal that could not be
weaned from ECMO was unstable because of hemodynamic
problems and not because of PGF. This finding was paral-
leled by clearly superior functional parameters in group B.
The observation that the wet/dry ratio in group A at time
point 2 was not significantly higher than that in group B is
controversial and probably due to the fact that 4 animals
with signs of lung edema already died thus far, and the
results are reflecting the remaining animals who performed
better. However, we consider wet/dry ratio as a weak param-
eter in this context, as far as other investigators also regis-
tered a decrease in lung water content after experimental
reperfusion conditions.19,31
These results provide evidence for several important facts.
Lung damage in our model was caused by a long cold ische-
mic period in lungs that was triggered by brain death. This
combination obviously results in such severe damage to
the graft that development of severe PFG becomes an
inevitable consequence under conventional implantation
strategies. Transplantation on venoarterial ECMO and pro-
longation of this support through a 22-hour period of reper-
fusion, however, maintains hemodynamic and oxygenatory
stability during this critical period of time and protects the
transplanted lung from further reperfusion injury. This pe-
riod of 22 hours is obviously sufficiently long enough that
the graft can recover from the injury obtained during brain
death and ischemic storage and can provide excellent organ
function thereafter. This suggests that the damage that donor
organs receive during transplantation occurs in a 2-stage
process. In stage 1 endothelial cell injury and increase in
capillary permeability occur during the storage and implan-
tation phase. The real injury to the graft, however, derives
from the second stage, when the preinjured graft becomes
prone to nonoptimal reperfusion conditions. During this pe-
riod, the injury to the lungs proceeds to severe PGF. One can
conclude that the importance of these reperfusion conditions
and the length of the critical time period have been underes-
timated thus far. Venoarterial ECMO, with the previously
mentioned features of reduction of CO and passing the pul-
monary vascular bed, in combination with protective venti-
lation obviously has the potential to prevent further progress
of graft damage and to allow for rapid healing of the already
existing injuries. However, the exact period of time needed
for lungs to recover from the ischemic damage is currentlyrdiovascular Surgery c Volume 137, Number 6 1497
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scribed period of the first 10 to 15 minutes after transplanta-
tion. Based on our clinical and experimental experience, this
time period should be 8 to 12 hours if dealing with early
signs of PGF and using ECMO in a preemptive manner
and between 24 and 48 hours if treating manifest PGF.
ECMO should be applied early in the course of lung dys-
function after transplantation to avoid further damage from
barotrauma and hemodynamic instability from maximal
ventilatory support.
These findings might well be of importance for the use
of marginal donor lungs and might help to expand the
current organ donor pool. This would be a valuable addi-
tion to the current efforts of ex vivo reconditioning of
donor lungs.18,19,32
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